Get started
Author

Tiffany Yau

Observed names: T.T. Yau, TIFFANY TSE LING YAU, Tiffany T.L. Yau, Tiffany TL Yau, Tiffany Tse Ling Yau
OpenAlex ID: A5111968443
Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study
2019 · Noel Yat Hey Ng, Guozhi Jiang, et al. · PLoS Medicine · 68
PDF
Polycystic ovary syndrome: a common reproductive syndrome with long-term metabolic consequences
2017 · Tiffany TL Yau, Noel YH Ng, et al. · Hong Kong Medical Journal · 48
PDF
Association of technologically assisted integrated care with clinical outcomes in type 2 diabetes in Hong Kong using the prospective JADE Program: A retrospective cohort analysis
2020 · Lee-Ling Lim, Eric S. H. Lau, et al. · PLoS Medicine · 37
PDF
Elderly burn prevention: A novel epidemiological approach
2007 · Pauline Wong, Vanessa Y.C. Choy, et al. · Burns · 27
Evolution of Diabetes Care in Hong Kong: From the Hong Kong Diabetes Register to JADE-PEARL Program to RAMP and PEP Program
2018 · Ivy H.Y. Ng, Kitty K.T. Cheung, et al. · Endocrinology and Metabolism · 20
Young-onset diabetes in women with Polycystic Ovary Syndrome: A territory-wide retrospective analysis in Hong Kong
2023 · Noel Y.H. Ng, Hongjiang Wu, et al. · Diabetes Research and Clinical Practice · 16
Association between FGF19, FGF21 and lipocalin-2, and diabetes progression in PCOS
2021 · Feifei Cheng, Noel Yat Hey Ng, et al. · Endocrine Connections · 15
GCK‐MODY in pregnancy: A pregnant woman with diabetes and a small‐for‐gestational‐age fetus
2022 · Tiffany Tse Ling Yau, Stephanie Cheuk Yin Yu, et al. · Clinical Case Reports · 8
PDF
The relationship between visceral adiposity and cardiometabolic risk in Chinese women with polycystic ovary syndrome
2021 · N.Y.H. Ng, K.H. Liu, et al. · Obesity Research & Clinical Practice · 5
Effects of Dorzagliatin, a Glucokinase Activator, on α- and β-Cell Function in Individuals With Impaired and Normal Glucose Tolerance
2025 · Zhengli Bai, Ke Wang, et al. · Diabetes · 1
PDF
Effects of dorzagliatin, a glucokinase activator, on α and β- cell function in individuals with impaired and normal glucose tolerance
2025 · Zhengli Bai, Ke Wang, et al.
PDF
Effects of dorzagliatin, a glucokinase activator, on α and β- cell function in individuals with impaired and normal glucose tolerance
2025 · Zhengli Bai, Ke Wang, et al.
1887-LB: Effect of Dorzagliatin, a Dual-Acting Glucokinase Activator, on Insulin and Glucagon Secretion in Impaired and Normal Glucose Tolerance
2024 · ZHENGLI BAI, KE WANG, et al. · Diabetes
Continuous subcutaneous insulin infusion: a local perspective
2023 · Tiffany TL Yau, Alicia J Jenkins, et al. · Hong Kong Medical Journal
PDF
Works count: 14
Citation count: 245
H-index: 8
I10-index: 7
Year
Topic
Type